Age‑Related Cutoffs for High‑Sensitivity Cardiac Troponin I

Diagnostic Thresholds

The European Society of Cardiology recommends that the diagnostic cut-off for NSTEMI is any hs-troponin value above the 99th percentile of the upper reference limit, combined with either a ≥20% relative change or an absolute change meeting assay-specific thresholds when serial measurements are obtained 6, 7, 8
The American College of Cardiology suggests that troponin elevation does not equal NSTEMI, and multiple non-ischemic conditions must be excluded 7, 9

The 99th percentile varies by manufacturer, with values of 14 ng/L for hs-cTnT (Elecsys; Roche), 16-20 ng/L for hs-cTnI (Architect; Abbott), 40-50 ng/L for hs-cTnI (Centaur; Siemens), and 17-19 ng/L for hs-cTnI (Access; Beckman Coulter) 6, 10

Serial measurements demonstrating dynamic changes are mandatory for NSTEMI diagnosis, with a ≥20% relative change or an absolute change meeting assay-specific thresholds required 7, 8, 9

The 2020 ESC guidelines provide a rapid rule-out and rule-in algorithm using assay-specific thresholds at 0 and 1 hour, with rule-out criteria including hs-cTnT <5 ng/L, hs-cTnI <4 ng/L, and hs-cTnI <3 ng/L at presentation 6, 10
Rule-in criteria include hs-cTnT ≥52 ng/L, hs-cTnI ≥64 ng/L, and hs-cTnI ≥120 ng/L at presentation, or absolute changes of ≥5 ng/L, ≥6 ng/L, and ≥12 ng/L at 1 hour, respectively 10

Clinical context is mandatory for NSTEMI diagnosis, with compatible ischemic symptoms, ECG changes, and exclusion of alternative diagnoses required 7, 9, 6
The key distinguishing feature of NSTEMI is the dynamic rise/fall pattern of troponin values, not the absolute value 7, 11
Elevations >5× the 99th percentile have >90% PPV for acute type 1 MI, but massive elevations can also occur with myocarditis, Takotsubo syndrome, or pulmonary embolism 12, 10